MTOR and breast cancer: Consist with that, GSEA showed that the PI3K‐AKT‐mTOR pathway was the only upregulated pathway in both tumor tissues of endocrine‐insensitive patients and endocrine‐resistant breast cancer cells (Figure S4D, Supporting Information).